Ładuje się......

Adrenal insufficiency development during chemotherapy plus anti-programmed death receptor-1 monoclonal antibody (tislelizumab) therapy in patients with advanced gastric cancer: two case reports

Immune checkpoint inhibitor (ICI)-associated adrenal insufficiency is rare but may become a serious adverse event in patients treated with ICIs. The present case report documents two cases of adrenal insufficiency developed during chemotherapy plus tislelizumab (百泽安, Baize’an; BeiGene Ltd.) therapy...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
1. autor: Jin Ho Baek
Format: Artigo
Język:Inglês
Wydane: Yeungnam University College of Medicine, Yeungnam University Institute Medical Science 2022-01-01
Seria:Journal of Yeungnam Medical Science
Hasła przedmiotowe:
Dostęp online:http://www.e-jyms.org/upload/pdf/yujm-2021-00934.pdf
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!